152 related articles for article (PubMed ID: 37711827)
21. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
[TBL] [Abstract][Full Text] [Related]
22. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
Razek AAKA
Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
[TBL] [Abstract][Full Text] [Related]
23. Apparent Diffusion Coefficient Map-Based Radiomics Features for Differential Diagnosis of Pleomorphic Adenomas and Warthin Tumors From Malignant Tumors.
Wen B; Zhang Z; Zhu J; Liu L; Li Y; Huang H; Zhang Y; Cheng J
Front Oncol; 2022; 12():830496. PubMed ID: 35747827
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?
Vernuccio F; Arnone F; Cannella R; Verro B; Comelli A; Agnello F; Stefano A; Gargano R; Rodolico V; Salvaggio G; Lagalla R; Midiri M; Lo Casto A
Br J Radiol; 2021 Dec; 94(1128):20210340. PubMed ID: 34591597
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Differentiation of Benign Parotid Gland Tumors.
Markiet K; Glinska A; Nowicki T; Szurowska E; Mikaszewski B
Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336773
[TBL] [Abstract][Full Text] [Related]
26. Conventional and Diffusion-Weighted MR Imaging Findings of Parotid Gland Tumors.
Eravcı FC; Sözmen Cılız D; Özcan KM; Çolak M; Çavuşoğlu M; Karakurt SE; Karakuş MF
Turk Arch Otorhinolaryngol; 2020 Sep; 58(3):174-180. PubMed ID: 33145502
[TBL] [Abstract][Full Text] [Related]
27. Enhanced CT combined with texture analysis for differential diagnosis of pleomorphic adenoma and adenolymphoma.
Xia F; Guo F; Liu Z; Zeng J; Ma X; Yu C; Li C
BMC Med Imaging; 2023 Oct; 23(1):169. PubMed ID: 37891554
[TBL] [Abstract][Full Text] [Related]
28. Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study.
Gabelloni M; Faggioni L; Attanasio S; Vani V; Goddi A; Colantonio S; Germanese D; Caudai C; Bruschini L; Scarano M; Seccia V; Neri E
Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33153140
[TBL] [Abstract][Full Text] [Related]
29. A multiparametric analysis combining DCE-MRI- and IVIM -derived parameters to improve differentiation of parotid tumors: a pilot study.
Patella F; Franceschelli G; Petrillo M; Sansone M; Fusco R; Pesapane F; Pompili G; Ierardi AM; Saibene AM; Moneghini L; Biglioli F; Carrafiello G
Future Oncol; 2018 Dec; 14(28):2893-2903. PubMed ID: 29425058
[TBL] [Abstract][Full Text] [Related]
30. CT-based radiomics with various classifiers for histological differentiation of parotid gland tumors.
Lu Y; Liu H; Liu Q; Wang S; Zhu Z; Qiu J; Xing W
Front Oncol; 2023; 13():1118351. PubMed ID: 36969052
[TBL] [Abstract][Full Text] [Related]
31. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D
Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994
[TBL] [Abstract][Full Text] [Related]
32. Radiomics-based comparison of MRI and CT for differentiating pleomorphic adenomas and Warthin tumors of the parotid gland: a retrospective study.
Liu Y; Zheng J; Lu X; Wang Y; Meng F; Zhao J; Guo C; Yu L; Zhu Z; Zhang T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):591-599. PubMed ID: 33602604
[TBL] [Abstract][Full Text] [Related]
33. Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation.
Ikeda M; Motoori K; Hanazawa T; Nagai Y; Yamamoto S; Ueda T; Funatsu H; Ito H
AJNR Am J Neuroradiol; 2004 Aug; 25(7):1256-62. PubMed ID: 15313720
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted MRI in the differential diagnosis of parotid malignancies and pleomorphic adenomas: can the accuracy of dynamic MRI be enhanced?
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jul; 124(1):95-103. PubMed ID: 28522187
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.
Wei P; Shao C; Tian M; Wu M; Wang H; Han Z; Hu H
Cancer Manag Res; 2021; 13():5423-5431. PubMed ID: 34262350
[TBL] [Abstract][Full Text] [Related]
36. Preoperative Diagnostic Strategy for Parotid Gland Tumors Using Diffusion-Weighted MRI and Technetium-99m Pertechnetate Scintigraphy: A Prospective Study.
Kikuchi M; Koyasu S; Shinohara S; Imai Y; Hino M; Naito Y
PLoS One; 2016; 11(2):e0148973. PubMed ID: 26849569
[TBL] [Abstract][Full Text] [Related]
37. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.
Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B
Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882
[TBL] [Abstract][Full Text] [Related]
38. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
Wang Y; Song L; Guo J; Xian J
Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
[TBL] [Abstract][Full Text] [Related]
39. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
[TBL] [Abstract][Full Text] [Related]
40. The Value of Multiparametric Magnetic Resonance Imaging in the Preoperative Differential Diagnosis of Parotid Gland Tumors.
Stoia S; Lenghel M; Dinu C; Tamaș T; Bran S; Băciuț M; Boțan E; Leucuța D; Armencea G; Onișor F; Băciuț G
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
